XI Congresso della Società Italiana di Psicopatologia Psichiatria ...

teria and having a history no compliance. The mean quetiapine
dose was 300 mg/day and 600 mg/day. Psychiatric disorders
were evaluated by a semi-structured interview including
the Structured Clinical Interview for DSM-IV Axis I (SCID-
I) and Personality Disorders (SCID-II).
The patients were assessed for Psychotic symptoms with the
Positive and Negative Syndrome Scale (PANSS); for depressive
symptoms with HAMD and MADRS; with Psychiatric
Rating Scale (BPRS) and CGI; for other symptoms
with HAMA, SCL-90; for obsessive-compulsive symptomatology
was detected according to the italian version of
the Leyton Obsessional Inventory; for adverse events (AEs)
were reported spontaneously.
Assessment: at baseline and at week 12 of quetiapine treatment;
Quetiapine was added to other medications, but other
antipsychotics.
Results: there was a significant effect of treatment on improvement
in PANSS total scores from baseline to endpoint
for patients with diagnosis Cluster A and Cluster B personality
disorders (72% reduction of positive symptoms in the
PANSS positive subscale and negative symptoms 54% reduction
of negative symptoms in the PANSS negative subscale;
p = 0.001).
The reduction in HAMDscores between the baseline (24.6 ±
2.1) and the endpoint (5.0 ± 2.0) was statistically significant
(p = 0.002). The reduction in HAMAscores between the
baseline (25.6 ± 4.1) and the endpoint (4.0 ± 2.0) was statistically
significant (p = 0.001). The most commonly observed
side effects included asthenia (8 patients, 32%),
weight gain (4 patients, 16%), and mild sedation (6 patients,
24%). Marked improvement in CGI after 12 week of treatment
was observed in 19 (76%) patients (8 patients, 32%
Cluster A; 9 patients, 36% Cluster B; 2 patients, 8% Cluster
C Personality Disorder).
Conclusions: this study suggests that quetiapine may be an
effective and well tolerated drug for treatment cluster A and
Cluster B personality disorders.
67. Anxiety and dental implantology:
symptoms anxious and outcome in
implantology. (At the private dental office)
P. Cimmino * , C. Cimmino, G. Palmigiano **
Psychiatry Emergency Hospital, Frattaminore, ASL Napoli
3, Napoli; * Private Implantology Dental Center, Napoli;
** University of Napoli, Federico II
Objective: the study aimed to evaluate the anxious symptoms
associated with dental implantology on 16 cases in a
private dental office
Methods: at this study was recruited a sample of 16 cases
awaiting dental implants (peri-implant soft tissue health status
of implants supporting overdentures with bar attachments
in the mandible; 16 cases = 43 implants). The sample was assessed
by work’s group of the Center for the study of Anxiety
and Depression Disorder of the Psychiatry Emergency Hospital
“San Giovanni di Dio” Frattaminre (Napoli) to exclude
a DSM-IV diagnosis of Anxiety and Depression Disorder.
At baseline, before surgery, the sample was evaluated with
instruments: PAAAS, HAM-A, SCL-90, that estimated re-
255
POSTER
spectivily the symptomatologic gravity and anxious characteristics.
The sample was divided in two groups on the basis of presence
[A-ANXIETY-: n° 9 (56.25%), 8 female = 50% and 1
male = 6.25%] or absence [NA-NO ANXIETY-: n° 7
(43.75%), 2 females = 12.5% e 5 males = 31,25] of presurgical
anxiety.
The aforementioned factor(anxiety) was evaluated
(PAAAS, HAMA, SCL-90) immediately after surgery, at 24
hours, and during a follow-up for a period of 1 year at intervals
of week; 1,2,3,4, and 6 months, and 1 year after.
All of implants were placed and evaluated by same clinician.
Dental implant clinical aspects postsurgical were evaluated
with a descriptive scale of five items on dental area and
ridges.
Results: the results of statistical analysis indicate a correlation
between anxiety and negative outcome in dental implantology,
in a private dental practice, at the level of significance
p = 0.002.
Conclusion: after an extensive review of dental literature,
few articles were found related to anxiety and implantology.
In this preliminary study, the group A with anxious symptoms
results characterized during follow-up 1years by higher
level of pain in the implanted area, neuralgia, edema,
headaches, pain during mastication, speech, opening, closing,
pain of the area of pterygoid and masseter muscles, intellectual
disorders: memory and concetration deficit.
Anxiety could represent negative predictor of outcome in
higher level of symptomatologic severity postsurgical and
greater expression late remission in dental implantology.
68. Il corpo come espressione di disagio
psichico: diverse modalità di comunicazione
M.E. Cinti, R. De Bellis, S. De Nitto, C. Tilocca, M. Di
Giusto
Dipartimento Scienze Psichiatriche e Medicina Psicologica,
Università di Roma “La Sapienza”
Introduzione: all’interno dei “significati psicologici” del
corpo, non c’è dubbio che il suo valore espressivo, come
strumento di comunicazione, sia tra i più pregnanti. Questa
dimensione si propone anche in psicopatologia, quando il
disagio psichico non può essere verbalizzato e viene manifestato
attraverso sintomi somatici. Ma il processo di somatizzazione
si può organizzare a diversi livelli, con diverse
dinamiche e conseguentemente con diversi orientamenti terapeutici.
Metodologia: le osservazioni si riferiscono due gruppi di
soggetti: 30 con sintomatologie somatiche che al colloquio
clinico potevano essere interpretate come sintomi di conversione,
e 30 con sintomatologie somatiche che non si configuravano
come disturbi di conversione. I soggetti, afferenti
alla UOC di Psicologia Clinica del Policlinico Umberto I,
sono stati sottoposti ad esame diagnostico mediante reattivi
mentali, quali il test di autovalutazione MMPI-2 ed il test
proiettivo DFU.
Risultati: è stata effettuata un’ANOVA per valutare le differenze
fra gruppi e una correlazione fra le scale dei reattivi
usati.